NMR and Computational Studies of NAD(P)(H) Cofactor Binding by Kim, Junghwa
Marquette University
e-Publications@Marquette
Master's Theses (2009 -) Dissertations, Theses, and Professional Projects
NMR and Computational Studies of NAD(P)(H)
Cofactor Binding
Junghwa Kim
Marquette University
Recommended Citation
Kim, Junghwa, "NMR and Computational Studies of NAD(P)(H) Cofactor Binding" (2011). Master's Theses (2009 -). Paper 117.
http://epublications.marquette.edu/theses_open/117
  
NMR AND COMPUTATIONAL STUDIES OF NAD(P)(H) COFACTOR BINDING 
 
 
 
 
 
 
 
by 
JUNGHWA KIM 
 
 
 
 
 
 
A Thesis submitted to the Faculty of the Graduate School, 
Marquette University, 
in Partial Fulfillment of the Requirements for 
the Degree of Master of Science 
 
 
 
 
 
Milwaukee, Wisconsin 
December 2011 
 
  
 ABSTRACT 
NMR AND COMPUTATIONAL STUDIES OF NAD(P)(H) COFACTOR BINDING 
JUNGHWA KIM, B.A. 
Marquette University, 2011 
 
Tuberculosis (TB) is one of the most dangerous diseases in a sense of spread method. According 
W.H.O., one third of world population has this disease and annual one of these infected people 
spreads 10 -15 people unintentionally. To protect human from this bacterial, the unique feature 
of mycrobacterial TB was studied previously. The unique cell wall, peptidoglycan, has high 
content of DAP (diaminopimelic acid). The disruption of synthesis DAP results in cell death due 
to instability of cell wall. One way to inhibiting synthesis of DAP is to modify cofactor which 
acts with dehydrogenase. To do that the study of cofactor is necessary.  
There are limitation for determination of Nitrogen and Oxygen by X-ray Crystallography. Recent 
research paper found several examples that Nitrogen and Oxygen of carboxamide on 
Nicotinamide adenosine dinucleotide (NAD(P)(H) were misplaced in X-ray crystallography. 
NMR is more accurate measurement on Nitrogen and Oxygen determination. For NMR studies, 
15N labeled cofactors are required due to a half spin property of Nitrogen. The synthesis of N15 
labeled cofactors, NAD(P)(H)\, will be addressed. Additionally, Energy, charge, NMR, 
resonance structures are studied with computational calculation, Gaussian 9.0 and NBO5. There 
are several distinctive differences between carboxamide conformation on NAD(P)(H) by 
Conjugation, Nitrogen, substituent, and steric hinderance effects.       
Our findings will help understanding of cofactors binding enzyme. It will facilitate the drug 
development.  
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Chapter I. Dynamic and structural changes of 
15
N labeled NAD(P)(H) with 
binding proteins 
1. Introduction 
Tuberculosis (TB) is a contagious disease that is transmitted via coughing, sneezing, or other aspiration 
that is transferred. The most dangerous part of TB is that people can be infected with TB bacilli for years, 
and do not feel sick until their immune system is weakened, at which point the TB becomes “active.” 
Active TB bacilli in infected people can spread TB unintentionally. According to the WHO 
(http://www.who.int/mediacentre/factsheets/fs104/en/), one-third of the world’s population has TB 
bacillus in their body and each infected person spreads TB disease on average to 10 -15 people in a year. 
Treatment for TB must continue for 4-6 months, using a cocktail of drugs: isoniazid, rifampin, 
ethambutol, and pyrazinamide. Recently, multidrug-resistant (MDR) strains of TB have emerged. The 
treatment of this resistant TB strain is done using so-called second-line treatments, which are more costly 
and have more side effects. Therefore, the development of new and more effective anti-tuberculosis drugs 
is necessary
1-3
.  
The distinctive composition of the peptidoglycan cell wall of mycobacterium is target of many drugs; it 
has a high degree of interpeptide cross-linking, primarily through meso-Diaminopimelic acid (DAP) 
cross-links in addition to the DAP. DAP biosynthesis is central to the structure of the mycobacterial 
peptidoglycan. So, DAP syntheses (and lysine synthesis) is a potential target for killing mycobacteria, 
such as Mycobacterium smegmatis and Mycobacteria tuberculosis. Disruption of biosynthesis of DAP 
results in cell death due to instability of the peptidoglycan
14,15
.There are three known methods for 
biosynthesis of DAP by mycrobacteria (Fig 1). The dihydrodipicolinatereductase (DHPR, also called 
2 
 
 
 
dapB) gene of mycobacteria is a potentially useful target for the development of new antibiotics, specific 
for mycobacteria, because its inhibition can inhibit of the three parallel biosynthetic pathways for the 
synthesis of DAP in mycobacteria, such as BCG (Bacterium bovis)
14
, as shown in Fig. 1. 
 
 
Figure 1. Three pathways for synthesis of meso-DAP and lysine. Three major pathways: 
Succinlyase pathway, Dehydrogenase pathway, Acetylase pathway. 
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Figure 2. Reaction with Dihydrodipicolinatereductase (DHPR, also called dapB) 
 
Figure 1 shows the pathway for synthesis of L-lysine in gram-negative bacterial and 
mycobacteriaincluding Mycobacterium tuberculosis (M. TB). 
Dihydrodipicolinatereductase (DHPR, also called dapB) catalyzes the NAD(P)H dependent reduction 
of the carbon- -unsaturated cyclic imine, dihydrodipicolinate, to form 
the cyclic imine, tetrahydropicolinate (Figure 2). Similarly, Dihydrodipicolinatereductase (DHPR), 
with help of a cofactor, the reduced form of Nicotinamide adenine dinucleotide phosphate (NADPH), 
converts dihydrodipicolinate to tetrahydrodipicolinate. Dihydrodipicolinate reductase (DHPR) is a 
potential drug target for treating TB4-6.  
NADP(H) is used as the cofactor for multiple enzymes in cell wall synthesis pathways, in addition to 
DHPR. The mechanism and structural study of NAD(H)/NADP(H) bound to these enzymes will 
improve our basic understanding of an important class of enzymes, but may also help guide the 
development of anti-TB drugs that inhibit these enzymes. And, given the importance of the NADPH 
cofactor in other enzymatic redox reactions, its mechanism is of broad interest.  
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The mechanism and structural conformation of enzyme-bound NAD(H)/NADP(H) are studied by 
computational and NMR methods presented herein. 
Figure 3 Lysine and meso-diaminopimelate (DAP) biosynthetic pathway in E. Coli 
4
. 
  
5 
 
 
 
1.1 Rationale for Design of Conformational Dynamics Ligand Probe 
In almost all living systems, most chemical reactions need enzymes to lower activation energy and 
increase reaction rates. In many case, enzymes require non-protein molecules called cofactors for their 
activities. Understanding in changes of conformational Enthalpy and Entropy due to interactions between 
substrate, cofactor, and protein is necessary to understand mechanism. An unbounded cofactor has higher 
entropic energy, since there are few restrictions on bond rotations. Once, a cofactor bounds to an enzyme 
is loses entropic energy, and enthalpy gains (ex. formation of hydrogen bonds; Van der Waals 
interactions) typically offset this entropic penalty. The study in Enthalpic and Entropic contribution to 
enzymatic reaction is now an important part of the drug design process.  
The reduced or oxidized forms of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine 
dinucleotide phosphate (NADP), one of largest classes of cofactors, are ubiquitous in all living systems. 
370 different kinds of enzymes according to Enzyme Nomenclature, and seventeen percent of all 
classified enzymes require NAD(P)(H)
11
. The weight of importance of these enzymes is significant.  
Undoubtedly, the characterization of dynamic changes in the NAD(P)(H) will improve understanding of 
enzymatic mechanisms in various enzymatic reactions, which reacts with NAD(P)(H).  
The possible conformational studies of NAD(P)(H) are derived from the base-ribose, glycosidic 
orientation, folded and opened forms, and the structure of the dihydronicotinamide ring
10,11
. 
In unbounded states, the conformation of pyridine dinucleotides in solution has three different 
conformations, extended, folded, and hydrogen-bonded. Among those conformations, a folded 
conformation with the planes of the two rings stacked in parallel is the most abundant, and exchanges 
with the open conformation
12
.  
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Previously the Sem lab used NMR relaxation dispersion methods to study the exchange between folded 
and opened conformations of free NAD(P)(H); the msec timescale conformational exchange was 
consistent with a proposed conformational exchange proposed by Jardetzky
13
, thereby validating our 
approach. The relaxation dispersion methods we use are based on Carr-Purcell-Meiboom-Gill (CPMG) 
based T2 measurements, which will be used to study conformational exchange rate changes that occur 
after coenzyme binds to protein. Such studies are based on measurements of the motional properties 
(reflected in T2 values) for the N-H amide bond vector; such experiments require that nitrogen be present 
as 15N (spin ½) rather than the naturally more abundant 14N (spin 1, and quadrupolar). So, synthesis 
of15N-NAD(P)(H) is therefore, needed, to help analyze the structural and dynamic information of the 
NAD(P)(H) cofactor by relaxation dispersion, as well as 15N-HSQC and 15N-filtered NOESY 
experiments. The studies presented herein are focused on the synthesis (chemical and enzymatic) of these 
labeled cofactors, to enable these NMR studies. 
1.2 Materials and Methods         
1.3 Synthesis of [
15
N-CA]-nicotinamide 
4.9 g KOH pellets and 60 mL deionized water were prepared in a 250 mL round bottom flask with a 
magnetic stir bar. After KOH pellets were dissolved completely, 1.5 g of 
15
N-NH4Cl was added to this 
solution. Additionally, 5.01g of Nicotinoyl chloride HCl (purchased from Sigma Aldrich) was added over 
10 min. pH of the solution was adjusted to 11. Solution was stirred for 2hrs, until completion of the 
reaction. For confirmation of [
15
N-CA]-nicotinamide formation, Figure 1, TLC was checked with 
comparison made to Isotope grade nicotinamide. Water was removed by lyphilizing. 0.72 g of 
4Åmolecular sieves and 50 mL of benzene were added into a dried 250 mL round bottom flask. Dried 
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powder of the 15N nicotinamide was transferred into the benzene solution. Reflux was performed 2-3 
hours by azeotropic distillation for additional water extraction. The Hot Solution was filtered with filter 
paper (P8) purchased from Fischer. The solution was filtered one more time with a fine filter funnel from 
Kontes Williamson: ST 14/20macroscale kit (purchased from Sigma-Aldrich). 17% of (0.589 g) [
15
N-
CA]-nicotinamide was the yield. For confirmation of 15N labeled Nicotinamide, a 1-D HSQC NMR 
experiment was performed at low Temperature 4°C, Figure 2.This NMR spectrum shows the signal for 
protons attached to 15N on the nicotinamide ring amide.  
N
Cl
O
HCl
+ 15NH3Cl
N
15NH2
O
pH 12.5
H2O
 
Figure 1.3.1 Chemical structure after 15N labeled NH3is added to the Pyridine.  
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Figure 1. 3. 2. 15N-HSQC filtered 1Dspectrum of 15N nicotinamide in 50mM Tris buffer, 4°C,pH 11, 
collected on a 600 MHz Varian NMR System.TheN-H that is anti to the carbonyl (at 8.1 ppm) is more 
acidic, and then N-H that is syn (7.3 ppm) less acidic. Lower pH leads to loss of signal intensity due to 
exchange with water (4.61 ppm). 
 
1.4Synthesis of [
15
N-CA]-NAD+ 
Reaction mixture containing 5 mM NAD, 50 mM of [
15
N-CA]-nicotinamide, in 20ml of 50mM Tris 
buffer, 200 units of porcine brain NADase (purchased from Sigma-Aldrich) of 50mM Tris buffer, and 
40ml of 50mM Tris buffer were prepared and pH of solution was adjusted to pH 7.3. Before incubating 
the above mixturesat 37°C, 1 mL of NAD+ and a mixture of 500 uL of NAD+ and 500uL of NADase 
were prepared separately as a control sample to confirm the full exchange of [
15
N-CA]-nicotinamide into 
NAD+. Control sample and the reaction mixture were started, incubating at 37°C until UV absorbance of 
9 
 
 
 
the control sample was recorded (figure 1.4.1), using the cyanide method
9
.10 uLofsample was added to 
990 uL of 1.0 M NaCN in a 1ml quartz cuvette, and1 mL of cyanide solution was used as a blank. The 
UV absorbance at 340 nm decreased (20 hours) from 0.0318 to 0.0058. This confirmed Nicotinamide ring 
detachment from NAD+, by the NADaseenzyme (note: in the presence of excess nicotinamide, there is 
simply a nicotinamide ring swap, rather than loss of nicotinamide ring). 
 
Figure 1.4.1Control sample of a mixture of 500 uL of NAD+ and 500uL of NADase; UV-absorbance at 
340nm was decreased from 0.0318 to 0.0058, due to loss of the nicotinamide ring from NAD+. A is the 
control sample at the beginning of NADase reaction after the CN reaction. B is the control sample at the 
middle of NADase reaction after CN reaction. C is the control sample at the end of NADase reaction after 
CN reaction.   
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Then the mixture was heated up to 70 °C for 2 minutes to deactivate the NADase enzyme. The 
deactivated protein was separated by centrifuging at 4000rpm, and supernatant was collected for further 
purification.  
 
 
Figure 1.4.2.Synthesis of 
15
N-NAD+ 
 
[
15
N-CA]-NAD+ was further purified using a BioGel P2 gel (Bio-Rad) column with 50mM Tris buffer at 
pH 7.3. The product purified was analyzed with the cyanide method
9
 to detect NAD+.To perform the 
assay, 10 uLof sample was added to 990 uL of 1.0 M NaCNin a 1ml quartz cuvette, and1 mL of cyanide 
solution was used as a blank.  
The final concentration of [
15
N-CA]-NAD+ was determined using an alcohol dehydrogenase enzymatic 
endpoint assay. To perform this assay, 10 uL of 2mM methanol, 10 uL (16 units)of yeast Alcohol 
Dehydrogenase (purchased from Sigma-Aldrich), and 50 uL of [
15
N-CA]-NAD+ were added to930uL of 
N
NH2
O
O
OH OH
OP
O
O
O
P OO
O
O
OH OH
N
N N
N
NH2
N
15NH2
O
O
OH OH
OP
O
O
O
P OO
O
O
OH OH
N
N N
N
NH2
N
15NH2
O
NADase/50mM Tris Buffer
PH 7.3, 37 oC, 22 hrs
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Tris buffer at pH 7.3.UV-absorbance at 340 nm was monitored in Figure 1.4.3, and concentration 
calculated using a molar extinction coefficient of 6220M - 1 cm - 1
16
. The concentration of 15N-NAD+ 
was calculated to be 864uM. The product was stored after either flash freezing inliquid nitrogen, or else 
after lyophilizing overnight.  
 
Figure 1.4.3 enzymatic end point assay to determine concentration of NAD+, using 10 uL of 2mM 
methanol, 10 uL(16 units) of yeast Alcohol Dehydrogenase (purchased from Sigma-Aldrich), and 50 uL 
of [
15
N-CA]-NAD+, added to 930uL of Tris buffer at pH 7.3, Absorbance= 0.269, Concentration= 864 
uM 
 
The stabilityof15N-NAD(P) after several freeze-thaw cycles was determined at various pH’s (2.3 - 7.3). 
The concentration of coenzymes was analyzed with alcohol dehyrdrogenase assay after each thaw. With 
12 
 
 
 
50mM Tris buffer at various pH (2.3 - 7.3), the concentration of 15N-NAD+ was constant, from 550 uM 
to 553 uM. However, with phosphate buffer with various concentrations (20mM to 200mM) at various 
pH’s (2.3-7.3) the stability of the coenzyme (15N-NAD+) was much lower, with concentrations going 
from 500 uM to 0 uM– determined using the KCN method and the alcohol dehydrogenase endpoint assay. 
Thus, phosphate buffer should be avoided. 
 
1.5 Synthesis of [
15
N-CA]-NADH 
5 ml of purified [
15
N-CA]-NAD+ was used for the enzymatic synthesis of NADH. 5ml of 0.02 units/ml 
yeast alcohol dehydrogenase (ADH), 5ml of 4.3 mM ethanol, and 10 ml of 50 mM Tris buffer (pH 8.0) 
were used to synthesis of NADH (Figure 1.5.1). The reaction was run at room temperature until UV-
absorbance at 340nm reached a plateau (figure 1.5.2).The concentration of NADH was calculated to be 
787 uM, based on absorbance at 340 nm. After the reaction was done, ADH enzyme was removed by 
ultrafiltration (Millipore, cutoff of3kDa). The concentration of NADH was determined once more with 5 
uL of NADH added to 995 uL of 50 mM Tris buffer at pH 8.0, after blanking with 1ml of 50 mM Tris 
buffer. The concentration of NADH was calculated to be 614 uM. The solution was flash frozen in liquid 
nitrogen. 
13 
 
 
 
 
Figure 1.5.1 Synthesis of 
15
N-NADH 
 
Figure 1.5.2 Alcohol Dehydrogenase enzymatic assay: 10 uL of NAD+, 5 uL of 4.3 mM Methanol, 10 uL 
of 3.73x10
-5
 units/ml of Alcohol dehydrogenase, 975 uL of 50 mM Tris buffer. Absorbance=0.0490, 
Concentration=787uM 
N
15NH2
O
O
OH OH
OP
O
O
O
P OO
O
O
OH OH
N
N N
N
NH2
Ethanol, 50mM Tris Buffer
Alcohol Dehydrogenase
PH 7.3, 25oC, 30 min
N
15NH2
O
O
OH OH
OP
O
O
O
P OO
O
O
OH OH
N
N N
N
NH2
H HH
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Figure 1.5.3 UV-Vis spectrum (scanned from 300 nm to 800 nm) for5 uL of NADH in 995 ul of 50 mM 
Tris buffer pH 8.0, Absorbance=0.0191, concentration=614 uM. 
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1.6Synthesis of [
15
N-CA]-NADP+      
5ml of 5 mM of NADP+ (purchased from Sigma), 5 mL of 50 mM of [
15
N-CA]-nicotinamide,and 5 mL 
of 200 units NADase (purchased from Sigma) were added to 10 mL of Tris buffer at pH 7.3. Before 
starting incubation of the NADase reaction at 37 °C, 1 mL of NADP+ and a mixture of 500 uL of 
NADP+ and 500uL of NADase were prepared as a control sample to confirm the full exchange of [
15
N-
CA]-nicotinamide with NADP+. Control sample and the reaction mixture were started, incubating at 
37 °C until UV absorbance of the control sample at 340 nm decreased (50 hours) from 0.0483 to 
0.0082by the cyanide method
9
, as described above.10 uL of sample was added to 990 uL of 1.0 M NaCN 
in a 1ml quartz cuvette, with cyanide solution was used as a blank. The absorbance at 340 nm was 
appears at 0.0558. 
The reaction sample was then heated up to 70 °C for 2 minutes to deactivate the NADase. The deactivated 
protein was separated by centrifuging at 4000 rpm and supernatant was collected for further purification.  
[
15
N-CA]-NADP+ was further purified using a BioGel P2 gel (Bio-Rad) column with 50mM Tris buffer 
at pH 7.3. The final concentration of [
15
N-CA]-NADP+ was determined using 400 uL of DMSO, 40uL of 
37.5 mM Glucose, 20 uL of [
15
N-CA]-NADP+, 2.3 uL Glucose 6 phospate dehydrogenase (100 units of 
G6PDH) and 538uL of Tris buffer at PH 7.3, in an enzyme endpoint assay
10
. Note the in the presence of 
DMSO, G6PDH will accept glucose as a substrate, in place of glucose-6-phosphate. Absorbance at 340 
nm was 0.390, corresponding to a concentration of [
15
N-CA]-NADP+ of3,135uM.UV-absorbacne 
between 300 and 900 nm was scanned for confirmation of [
15
N-CA]-NADPH production; absorbance at 
340 nm allowed calculation of a concentration of  3199uM, consistent with that measured from the first 
assay. The [
15
N-CA]-NADP+ stock solution was frozen in liquid nitrogen or lyophilized overnight.  
16 
 
 
 
 
Figure 1.6.1 Enzyme endpoint assay with glucose-6-phosphate dehydrogenase (G6PDH):400 uL of 
DMSO, 40 uL of 37.5 mM Glucose, 20 uL of [
15
N-CA]-NADP+, 2.3 uL G6PDH (100 units), and 538uL 
of Tris buffer at PH 7.3. Concentration=3,135uM. 
  
17 
 
 
 
 
Figure 1.6.2 UV-Vis spectrum (scanned from 300 nm to 800 nm): Expected band is present at 340 nm for 
NADPH, and confirmation of concentration: 558 uLof 50 mM Tris Buffer, 400 uL of 99.8% DMSO,40 
uL 1.5 M glucose, 2 uL of G6PDH, 20 uL of NADP+. Spectrum was taken right after reaction was done. 
Concentration=3199 uM 
 
1.7 Synthesis of [
15
N-CA]-NADPH         
5ml of [
15
N-CA]-NADP+ purified previously was used for enzymatic NADPH synthesis. 0.25ml of a 
solution that is 100 units/ mL Glucose 6 Phosphate Dehydrogenase, 4 ml of 99.8% DMSO, 0.75 ml of 
100 mM Glucose, and 5 ml of[
15
N-CA]-NADP+ in Tris buffer at PH 8.0 were used for NADPH synthesis. 
The reaction was run at room temperature until UV-abosrbance at 340 nm reached a plateau, at 0.230 
(Figure 1.7.1). The calculated concentration of [
15
N-CA]-NADPH based on absorbance at 340 nm was 
1848 uM. After the reaction was done, Glucose-6-Phosphate Dehydrogenase enzyme was removed by 
ultrafiltration (Millipore, cutoff of 3kDa). The solution of [
15
N-CA]-NADPH was lyophilized to remove 
solvent.  
18 
 
 
 
 
Figure 1.7 Glucose-6-phosphate Dehydrogenase (G6PDH) endpoint assay:125 uL of 100 units Glucose 6 
Phosphate Dehydrogenase, 400 uL of 99.8% DMSO, 75uL of 100mM Glucose, and 20uL [
15
N-CA]-
NADP+ in 480 uL Tris buffer at pH 8.0. Absorbance=0.230, concentration=1848 uM. 
1.8 1D HSQC  
 
Figure 1.8.1 1D-15N-filtered HSQC of 15N-NAD+ 
19 
 
 
 
 
Figure 1.8.2 1D-15N-filtered HSQC of 15N-NADH at pH 11 
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Figure 1.8.3 1D-15N-filtered HSQC of 15N-NADH at pH 2.4 
 
Figure 1.8.4 1D-15N-filtered HSQC of 15N-NADH at Temperature 5ºC 
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Figure 1.8.5 1D-15N- filtered HSQC of NADP+ 
 
Figure 1.8.6 1D-15N- filtered HSQC of NADPH 
 
1D-HSQC was collected on a 600 MHz Varian spectrometer at room temperature. The water peak was 
used as a reference and calibrated at 4.6 ppm. 
The chemical shift of H-anti between NAD+ and NADP+ was from 8.072 to 8.090. The chemical shift of 
H-syn between NAD+ and NADP+ was from 7.261 to 7.273.  
The chemical shift of H-anti between NADP+ and NADPH was from 8.090 to 8.111. The chemical shift 
of H-syn between NAD+ and NADP+ was from 7.273 to 7.291.   
After synthesis of NADH, pH of NADH in Tri buffer solution was adjusted to 11 due to stability of 
cofactor at different pH (Section 1.4.) At the high pH (pH: 11), No peaks from hydrogens on carboxamide 
22 
 
 
 
were observed at room temperature (Figure 1.8.2). No peaks from hydrogens on carboxamide were 
observed at pH 7.9 and room temperature. At the reduced temperature (5 ºC), only one peak from 
hydrogens on carboxamide was observed at pH 7.9. pH was reduced to 2.5 and two peaks from hydrogens 
on carboxamide were observed.        
From 1D-HSQC, the synthesis of 
15
N-labeled cofactors were confirmed.  
  
1.9 Results and Discussion         
[
15
N-CA]-NAD(H) was synthesized successfully and the concentration and activity of the cofactor were 
confirmed with alcohol dehydrogenase assays by UV-vis spectroscopy. The concentration of [
15
N-CA]-
NAD+ was not changed after several freeze-thaw cycles in a pH range between 2 and 7.3 in Tris buffer. 
[
15
N-CA]-NADH was stable in the pH range between 7.3 and 12 in Tris buffer. NAD+ is known to be 
base labile, and NADH is acid labile, so careful attention to pH is important when storing cofactor for 
extended periods 
[
15
N-CA]-NADP(H) was synthesized successfully and the concentration and activity of the cofactor was 
confirmed with a G6PDH endpoint assay in 40% DMSO. The concentration of [
15
N-CA]-NADP+ was not 
changed after several freeze-thaw cycles in the pH range between 2 and 7.3 in Tris buffer.  [
15
N-CA]-
NADPH was stable in the pH range between 7.3 and 12 in Tris buffer.  
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1.10 Conclusion  
15
N-labeled cofactors NAD(P)(H) have been synthesized successfully. The problem with stability of these 
cofactors was resolved by using Tris buffer instead of phosphate buffer. After 8 freeze-thaw cycles over 
one month, the concentration was maintained, as assessed by UV-Vis spectroscopy analysis. The 1D- 
HSQC spectra confirmed that 
15
N-labeled cofactors NAD(P)(H) were produced. These 
15
N labeled 
cofactors will be used as probes to study cofactor geometry with 
15
N NOESY, and in dynamics studies 
using CPMG-based relaxation dispersion measurements.    
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2. Introduction 
Enzymatic structure and dynamics have been studied with various computational methods along 
with NMR and X-ray crystallography studies
11
. Certain structural questions regarding cofactors 
in oxidoreducatase reactions, regarding the conformation of the NAD(P)(H) (Figure 2.3 and 
Figure 2.4) cofactor, are of interest in the studies presented herein. Of particular interest is 
conformation and dynamics of the nicotinamide ring when bound to enzymes, since orientation 
of the carboxamide group is often ambiguous due to the limitation of X-ray crystallography. In 
X-ray crystallography analysis, the Nitrogen and Oxygen in the amide group in Nicotinamide 
Nucleotides is often not easy to distinguish
105
. Both dihedral angle X ≈ 180 º position16,17 of 
amide and dihedral angle X ≈ 0 º position10, 18,19, 20 of amide are possible (figure 2.1), although 
both are not observed with equal frequency – suggesting one orientation is either more favorable 
energetically, or more suitable for the reaction catalyzed by oxidoreductases.  
Thus, our interest is the dihedral angle, C3- C2- C6- O’ (figure 2.2), of the amide in the 
nicotinamide ring of the NAD(P)(H) cofactor. The dihedral angle, X ≈ 0 º, of C3-C2-C6-O’ in 
nicotinamide adenine dinucleosides (figure 2.2) was observed in X-ray crystallography about 90% 
of the time according to a survey of crystal structures reported by the Sem lab. The opposite 
angle, X ≈ 180 º, of C3-C2-C6-O’ in the nicotinamide ring was observed only about 10% of the 
time. 
15
N –filtered NOESY measurements with 15N labeled cofactors will be used confirm this 
results, or correct errors that may have been made, based on improper determination of Nitrogen 
and Oxygen atoms of the amide in X-ray crystal structures (perhaps the X ≈ 180 º conformation 
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is observed 100% of the time). Computational studiesare used to explore and propose the 
rationalefor any preferred conformations and mechanisms, by analysis of energy, charge, and 
resonance structures of NAD(P)(H) cofactors and simplified model derivatives, using Gaussian 9 
and NBO5. 
Understanding of structural preferences and mechanism will help to improve our understanding 
of the hydride transfer reaction involving NAD(P)+ and NAD(P)H with oxidoreductase enzymes. 
This understanding may also facilitate drug design efforts, where inhibitors are rationally 
designed to bind cofactor binding sites, or that span cofactor and substrate binding sites 
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Dihedral angle (X) of C8-C6-C1-O2 = 180 degree
Figure 2.1 Dihedral angle (X) of carboxamide X ≈ 0 º on the left, and dihedral angle (X) of 
carboxamide X ≈ 180 º on the right 
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Figure 2.2 Numbered atoms in Nicotinamide nucleoside as used for Gaussian calcualation, 
Dihedral angle of O2-C1-C6-C8 is called X, The figure shows an example of X ≈ 0 º.  
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Figure 2.3. Nicotinamide Adenine Dinucleotide, Oxidized Form (NAD+) on the left; 
Nicotinamide Adenine Dinucleotide Phosphate, Oxidized Form (NADP+) on the right 
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Figure 2.4Nicotinamide Adenine Dinucleotide, Reduced Form (NADH) on the left; 
Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form (NADPH) on the right 
 
2.1 Materials and Methods 
Herein, we used Gaussian 9.0 and NBO5 on Marquette’s Pere cluster. Gaussian 9 is used for 
geometric optimization and analysis of energy, charge, spectroscopy, and structure with Density 
map function (DMF). The hybrid density functional b3lyp with 6-31(G) basis sets was used for 
analysis.  After optimization with Gaussian 9, input filesfrom Gaussian 9.0 were used for NBO5, 
which was provided from Dr. Timerghazin, for resonance structure calculations. 
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Simplified derivatives (model compounds) of reduced or oxidized forms of Nicotinamide 
Adenosine Dinucleotide (Phosphate), NAD(P)(H), were drawn in Gaussian View (Figure 2.2). 
The input file was edited as in Figure 2.1.1, and Gaussian geometric optimizations performed, 
using b3lyp/6-31g(d).    
 
 
Figure 2.1.1 Geometry optimization input file 
 
The output file from geometric optimization was edited for geometric check or rotational energy 
calculation or spectroscopy analysis (Figure 2.2.2).  The output file from geometric check was 
also editedto create the NBO input file (Figure 2.2.3). Additionally, bond length, charge, dihedral 
angle, vibration, and energy scan results were analyzed with Gaussian View. 
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Figure 2.1.2 Input file for geometric check or rotational energy calculation or spectroscopy 
calculations. 
 
Figure 2.1.3 Input file for NBO5 calculations. 
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2.2. Rotational Energy of NAD(P)(H) 
Recent article published for x-ray crystallography related to NAD(P)(H) shows the conformation 
of amide position, X ≈ 0 º, is the most abundant. Analysis of potential energy according to the 
rotation of amide in NAD(P)(H) provides understanding ofrelationship between the most 
abundant and the most stable structure. If the most abundant structure is not the most stable 
structure, enzymatic catalyst reaction has to at least overcome this energy cap additionally. This 
may be a clue for rationalization of enzymatic reaction in the aspect of cofactors.  
The potential energies were calculated as a function of the bond rotation between C1 and C6, 
amide structure in Nicotinamide. The bond was rotated every 10 º from 0º to 360º. The structure 
of the cofactor, NAD(P)(H), is a relatively large molecule for a computational study. Because the 
effects from distal elements are likely to be insignificant, simplified derivative molecules, 
Propene, Nicotinamide, and Nicotinamide nucleoside of NAD(P)(H) were used for geometry 
optimization and other computational studies. 
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STUDIES OF OXIDIZED NICOTINAMIDE RING AND ANALOGS 
 
Figure 2.2.1 Rotational Energy of C1-C6 bond in Oxidized NicotinamideNucleoside ,  X= 0 º 
is Dihedral angle of O2-C1-C6-C8 =0 º, Structure “A” was geometrically optimized.  
33 
 
 
 
Figure 2.2.2 Structure A from energy diagram in Figure 2.2.1, at X= -22.66º, Energy = 5.0 
KJ/mole. The glycosidic bond (N15-C16) is in the syn conformation.  
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Figure 2.2.3 Structure B from energy diagram in Figure 2.2.1, X= 19.01 º, Energy = 7.0 KJ/mole. 
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Figure 2.2.3 Structure C from energy diagram in Figure 2.2.1, X= 85.42 º, Energy = 20.1 
KJ/mole. 
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Figure 2.2.4 Structure D from energy diagram in Figure 2.2.1, X= 160.17 º, Energy = 1.2 
KJ/mole. 
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Figure 2.2.5 Structure E from energy diagram in Figure 2.2.1, X= 206.60 º, Energy = 0.0 
KJ/mole. 
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Figure 2.2.6 Structure F from energy diagram in Figure 2.2.1, X= 281.60 º, Energy = 17.3 
KJ/mole. 
 
Preferred geometry for the carboxamide group.The dihedral angle of O2-C1-C6-C8 =0 º was 
set as X= 0 º. The energy of rotational energy was normalized to the lowest energy structure, 
Structure “E”, which had X ≈ 180 º, potential energy = 0 KJ/mole. The potential energy of X= -
22.7º, X=0 º, and X=19.0 º structures were 5.0 KJ/mole, 7.9KJ/mole, and 7.0 KJ/mole 
respectively. Comparing all conformations, the X= -22.7 º structure is the stable and in local 
minimum as a structure “A”. This conformation is called the X ≈ 0 º structure.   
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The potential energy of X= 160.2º, X=180.0 º, and X=206.6 º structures were 1.2 KJ/mole, 1.1 
KJ/mole, and 0.0 KJ/mole respectively. Among these three structures, the X=206.6 º structure is 
the most stable (structure “E”). This conformation is called the X ≈ 180 º structure. Therefore, 
the most stable structure of Nicotinamide is Structure “E” over all. The energy difference 
between structures “A” and “E” is 5.0 KJ/mole. Therefore, an enzyme would need to overcome 
at least 5.0 KJ/mole to bind the less favored X ≈ 0 º geometry more favorably. This may, 
therefore, explain why the X ≈ 0 º geometry is the one that is observed more commonly in crystal 
structures. 
The carboxamide is not planar. There is steric hindrance between the Hydrogen attached the 
carboxamide nitrogen (N3) in the amide group and the hydrogen attached to carbon C7 (also to 
C8, in the other conformation). The actual distance between hydrogens is below 2.50 Å. 
Therefore, the X = 0 º structure is not as stable a conformation compared to the other two 
structures (X= -22.7ºand X=19.0 º) that show a 20 degree distortion from planarity, to overcome 
the steric hindrance.But, the small energy differences suggest that even modest interactions with 
enzymatic groups could allow a range of geometries between -20 and +20 degrees. 
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Figure 2.2.7 Rotational Energy of C1-C6 bond in Oxidized Nicotinamide, X= 0 º is Dihedral 
angle of O2-C1-C6-C8 =0 º, Structure “A” was geometrically optimized. This energy profile, in 
comparison with that in Fig. 2.2.1, is for the nicotinamide ring with a methyl attached to the 
pyridine nitrogen, rather than the full ribose ring. 
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Figure 2.2.8 Structure A from energy diagram in Figure 2.2.7, X= -25.56 º, Energy = 7.7 
KJ/mole. 
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Figure 2.2.9 Structure B from energy diagram in Figure 2.2.7, X= 24.44 º, Energy = 7.8 KJ/mole. 
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Figure 2.2.10 Structure C from energy diagram in Figure 2.2.7, X= 84.45 º, Energy = 19.0 
KJ/mole. 
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Figure 2.2.11 Structure D from energy diagram in Figure 2.2.7, X= 154.45 º, Energy = 0.3 
KJ/mole. 
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Figure 2.2.12 Structure E from energy diagram in Figure 2.2.7, X= 194.45 º, Energy = 0.0 
KJ/mole 
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Figure 2.2.13 Structure F from energy diagram in Figure 2.2.7, X= 264.45 º, Energy = 17.6 
KJ/mole. 
 
The dihedral angle of O2-C1-C6-C8 =0 º was set as X= 0 º, and the energies were normalized to 
the lowest energy structure, Structure “E”, which had X ≈ 180 º, potential energy = 0 
KJ/mole.The potential energy of X= -25.56º, X=0 º, and X=24.44 º structures were 7.7 KJ/mole, 
8.1 KJ/mole, and 7.8 KJ/mole respectively. Among the three structures, the X= -25.56 º structure 
(structure “A”) is a local minimum. This conformation is called the X ≈ 0 º structure.   
The potential energies of the X= 154.45º, X=180.0 º, and X=194.45 º structures are 0.3 KJ/mole, 
0.3 KJ/mole, and 0.0 KJ/mole respectively. Among three structures, the X=194.45 º 
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structure(structure “E”) is the most stable and in a global minimum. This conformation is 
referred to as the X ≈ 180 º structure. Therefore, the most stable structure of Oxidized 
Nicotinamide is Structure “E” , the same as when the full ribose ring was present (see Fig. 2.2.1). 
The energy difference between structure “A” and “E” is 7.7 KJ/mole. This is a somewhat larger 
difference (by 2.7 KJ/mol) than was observed in the presence of the ribose ring, but still reflects 
the same geometric preference for the carboxamide group, which is opposite to the preference 
found most often for cofactor bound to enzyme.  
As before, there is steric hinderance between Hydrogen the carboxamide amide nitrogen (N3) in 
the amide group and the hydrogen attached to carbon C7 (also to C8, in the other conformation). 
The actual distance between hydrogens is below 2.57 Å. Therefore, the X = 0 º structure is not as 
stable a conformation compared to the other two structures: X= -25.56ºand X=24.44 º.  
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Figure 2.2.14 Rotational Energy of C1-C6 bond in Propene Carboxamide; X= 0 º is the 
Dihedral angle of O2-C1-C6-C8 =0 º, and Structure “A” was geometry optimized. Compared to 
energy diagrams in Figures 2.2.1 and 2.2.7, this is a much simpler model compound, with 
propene in place of the pyridine ring, which is attached to the carboxamide group that is being 
rotated. 
 
Figure 2.2.15 Structure A from energy diagram in Figure 2.2.14, X= 1.30 º, Energy = 1.2 
KJ/mole 
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Figure 2.2.16 Structure B from energy diagram in Figure 2.2.14, X= 81.30 ºEnergy = 18.5 
KJ/mole. 
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Figure 2.2.17 Structure C from energy diagram in Figure 2.2.14, X=151.30 ºEnergy = 0.0 
KJ/mole. 
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Figure 2.2.18 Structure D from energy diagram in Figure 2.2.14, X= 211.30 ºEnergy = 0.0 
KJ/mole. 
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Figure 2.2.19 Structure E from energy diagram in Figure 2.2.14, X= 281.30 ºEnergy = 18.6 
KJ/mole. 
 
The dihedral angle of O2-C1-C6-C8 =0 º was set as X= 0 º and the energies were normalized to 
the lowest energy structure, Structure “E”, which hadX ≈ 180 º, potential energy = 0 
KJ/mole.The potential energy of the X= 1.30º structure was 1.2 KJ/mole. The X= 1.30 º structure 
(structure “A”) is the most stable. This conformation is referred to as the X ≈ 0 º structure.  The 
energy difference between structure “A” and structures “C” or “D” was only 1.2 KJ/mole. That 
is, the difference between carboxamide geometries is much smaller in the propene model 
compound, than in the context of the pyridine ring of the nicotinamide. 
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The potential energy of the X= 151.30º, X=180.0 º, and X=211.30 º structures were 0.0 KJ/mole, 
3.5 KJ/mole, and 0.0 KJ/mole respectively. Among these three structures, the X=151.30 º and 
X=211.30º structures are the most stable (structures “C” and “D”). This conformation we call the 
X ≈ 180.0 º structure. Therefore, the most stable structuresare Structures “C” and “D”. But, in 
this propene derivative, the transition state barrier that must be traversed, in interconverting these 
structures, is higher than for the carboxamide attached to the pyridine group (Figures 2.2.1 and 
2.2.7). 
As before, there is steric hinderance between Hydrogen the thecarboxamide amide nitrogen (N3) 
in the amide group and the hydrogen attached to carbon C7 (also to C8, in the other 
conformation). The actual distance between hydrogens is below 2.56769 Å. Therefore, the X = 0 
º structure is not as stable a conformation compared to the other two structures: X= -25.56º and 
X=24.44 º.  
The distance between the hydrogen on the methyl and the hydrogen on the amide was 2.21707 
Å. Therefore, there is no steric hindrance.  
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STUDIES OF REDUCED NICOTINAMIDE RING 
 
Figure 2.2.20 Rotational Energy of C1-C6 bond in Reduced Nicotinamide, X= 0 ºis Dihedral 
angle of O2-C1-C6-C8 =0 º, Structure “A” was geometry optimized.  
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Figure 2.2.21 Structure A from energy diagram in Figure 2.2.20, X= -15.58 ºEnergy = 7.6 
KJ/mole. 
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Figure 2.2.22 Structure B from energy diagram in Figure 2.2.20, X= 15.37 ºEnergy = 8.5 
KJ/mole. 
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Figure 2.2.23 Structure C from energy diagram in Figure 2.2.20, X= 81.86 ºEnergy = 36.7 
KJ/mole. 
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Figure 2.2.24 Structure D from energy diagram in Figure 2.2.20, X= 179.18 ºEnergy = 0.0 
KJ/mole. 
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Figure 2.2.25 Structure E from energy diagram in Figure 2.2.20, X= 260.75 ºEnergy = 36.6 
KJ/mole. 
 
The dihedral angle of O2-C1-C6-C8 =0 º was set as X= 0 º and the energies were normalized to 
the lowest energy structure, Structure “D”, which hadX ≈ 180 º, potential energy = 0 
KJ/mole.The potential energiesfor theX= -15.58º, X=0 º, and X= 15.37 º structures were 7.6 
KJ/mole, 11.9 KJ/mole, and 8.5 KJ/mole respectively. Among these three structures, the X= -
15.58 º structure (structure “A”) is the most stable. This conformation we call the X ≈ 0 º 
structure.  The energy difference between structures “A” and “D” is 7.6 KJ/mole, the same as 
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that calculated for the oxidized nicotinamide ring, and with the same geometric preference for 
the carboxamide group. In comparing results from the various studies, the energy difference 
favoring the experimentally observed preferred geometry for the carboxamide group is not 
affected by redox state for the nicotinamide ring (it is the same for pyridine and dihydropyridine 
forms), is slightly diminished in the native cofactor with the ribose ring present (5 kJ/mole). But, 
in a simple allyic system (propene), there is little energy difference between the two 
carnxoamide geometries. 
The potential energy of the X= 179.2 º structureis0.0 KJ/mole. X=179.2 º , and this structure 
(structure “D”) is the most stable. This conformation wecallthe X ≈ 180.0 º structure. Therefore, 
the most stable structure of Reduced Nicotinamide is Structure “D”, which is consistent with the 
above calculations for related structures.. 
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Figure 2.2.26 Top diagram: unbalanced energy diagram was taken from calculations used to 
generate Figure 2.2.1. Middle Figure: Snapshot from a portion of the Nicotinamide Nucleoside.  
Bottom Figure: left panel is for X= -22.66 º, Structure “A”, and right panel is for X= 19.01 º, 
structure “B”. 
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The Energy difference between structuresA and B is not from steric hindrance between H4 on 
the amide and H9 and H11 on the pyridine in the Nicotinamide Nucleoside. The unbalanced W 
shape for the energy diagram (Figure 2.2.36, the middle Figure) came from the distortion of the 
pyridine structure. The shape of the pyridine forstructures “A” and “F” is a boat shape (bigger 
distortion, Figure 2.2.28), which was presented previously by Cook, P. F. 
103
.The structures “C” 
and “E” are a somewhat distorted shape, close to planar.  According to the Cook study103, the 
boat conformationbreakstheresonance on the Nicotinamide ring, so the Carboanion character 
Nicotinamideis localized at C-8 (Figure 2.2.27), making it susceptible to nucleophilic attack (and 
facilitating the hydride transfer reaction). The broken resonance structure “A”, with the boat 
conformation, can be selectively stabilized in the enzyme active site to facilitate reaction. 
The energy difference between the two carboxamide geometries (X ~ 0 or 180 degrees) in the 
Nicotinamide Nucleoside and Nicotinamidewas 5.0 KJ/mole and 7.7 KJ/mole respectively. One 
important question is why the energy difference is smaller in Nicotinamide Nucleoside than in 
Nicotinamide; what effect is the ribose ring having? Ribose is acting as an electron withdrawing 
group which will weaken the resonance structure of Nicotinamide resonance structure.This 
supports the hypothesis that the structure in Nicotinamide Nucleoside is stabilized by resonance 
structures in pyridine ring.  
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Figure 2.2.28 Dihedral angle of Pyridine in Nicotinamide Nucleoside. Using the above diagram, 
the shape of pyridine structure was drawn. Structure “A” has boat shape.  
 
Figure 2.2.29 Energy calculation of Benzene (left) and Pyridine (right) substituent between X ≈ 0 
º and X ≈ 180 º was calculated.  
 
The geometrical optimizations of Benzene and Pyridine substituent which are showing in Figure 
2.2.29 were performed. The Carboxamide group was rotated by 180 º. The energy of two 
structures of Benzene and Pyridine substituent were compared. The benzene structure was same 
in Energy. However, the energy of pyridine substituent was different in 7.5 KJ/mole (X ≈ 0 º 
structure was less stable than X ≈ 180 º). 
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  Nicotinamide 
Ribose  
Nicotinamide  Pyridine 
Substitent 
Benzene  
 -R group Ribose  Methyl  Hydrogen  -  
∆E                    
0º vs 180º  
(KJ/mole) 
5 7.7 7.5 0 
Figure 2.2.30 Energy change after rotation of X 
According to Figure 2.2.30, the substituent attached to N+ influenced the energy different 
between X ≈ 0 º and X ≈ 180 º. More electron withdrawing group such as Ribose reduced the 
energy difference between X ≈ 0 º and X ≈ 180 º. The opposite effect was observed with electron 
donating group such as methyl. The oxygen on ribose can have interaction with hydrogen on 
hydrogen on carboxamie. This needs to be investigated further more.  
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2.3 Calculated charges on nicotinamide ring atoms of NAD(P)(H) 
+
OO
H
OH
OO
H
H
OO
H
OH
H
H
H
+ CO2 + NADH
NAD
 
Figure 2.3.1 Malic Enzyme (ME) Reaction with the NAD+ Cofactor
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The NAD(P)+ cofactor is reduced to NAD(P)(H) by various oxidoreductase enzymes, including 
Malic Enzyme (Fig. 2.3.1). A hydride (proton and 2 electrons) is added to C8 of the nicotinamide 
ring (figure 2.3.2) in a reversible reaction. In general, oxidoreductase reactions involve hydride 
transfer to and from this position, and the transition state likely involves control of carbocationic 
character at this carbon, which may be tuned via enzymatic control of the pyridine ring geometry 
and interactions with the carboxamide group. An atomic charge analysis of NAD(P) will help the 
understanding of which factors play the most effective role in controlling this reaction. 
Calculation of charges (Table 2.3.1) supports the hypothesis that the Ribose is acting as an 
electron withdrawing group, which weakensresonance structures of the pyridine ring. The charge 
on C8 of the Nicotinamide Nucleoside and Nicotinamide was -0.177 and -0.069 at X ≈ 0 º., 
which is generally more positively charged than for X ≈ 180 º (-0.19 and -0.099). While this is 
somewhat true for the oxidized nicotinamide, it is especially true for the reduced nicotinamide 
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where charge increases from -0.6 to -0.3. The Ribose affects charge on C8 as well, making it 
slightly less negative (weakly electron withdrawing, through resonance effects).   
Name of 
molecule 
X ≈ 180 º 
Oxidized 
N-N 
X ≈ 0 º 
Oxidized 
N-N 
X ≈ 180 º 
Oxidized 
N 
X ≈ 0 º 
Oxidized 
N 
X ≈ 180 º  
Reduced N 
X ≈ 0 º 
Reduced N 
C1 0.549 0.527 0.605 0.571 0.542 0.521 
O2 -0.53 -0.501 -0.469 -0.442 -0.545 -0.512 
N3 -0.768 -0.76 -0.758 -0.750 -0.768 -0.757 
H4 0.335 0.329 0.359 0.351 0.33 0.317 
H5 0.332 0.331 0.385 0.383 0.333 0.33 
C6 0.002 0.01 0.013 0.014 0.01 0.004 
C7 0.049 0.016 0.112 0.082 0.061 0.037 
C8 -0.19 -0.177 -0.099 -0.069 -0.631 -0.322 
H9 0.204 0.168 0.264 0.230 0.18 0.147 
C10 -0.167 -0.169 -0.164 -0.165 -0.169 -0.171 
H11 0.094 0.135 0.208 0.245 0.135 0.168 
H11' - - - - 0.152 0.152 
C12 0.009 0.006 0.119 0.121 0.079 0.068 
H13 0.127 0.129 0.227 0.230 0.127 0.128 
H14 0.164 0.165 0.239 0.239 0.141 0.138 
N15 -0.473 -0.474 -0.387 -0.382 -0.431 -0.427 
Table 2.3.1 Charge analysis* for Nicotinamide Nucleoside (N-N) andNicotinamide (N) 
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2.4 Resonance structures forNAD(P)(H) 
 
 
Entry Resonance structure Resonance Weight (%) 
1 
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H
H H
H
H
 
58.48 % 
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H H
H
H
 
26.95 % 
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0.41 % 
72 
 
 
 
9 
N
O
H
H
H
H
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Figure 2.4.1 Resonance structure and weight of Acrylamide at X ≈ 0 º 
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Figure 2.4.2 Resonance structure and weight of Acrylamide at X ≈ 180 º 
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Figure 2.4.3 Resonance structure and weight of Methyl acrylamide at X ≈ 0 º 
   *Structure 10: Total resonance weight of both H11 and H12 detached from C10  
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Figure 2.4.4 Resonance structure and weight of Methyl acrylamide at X ≈ 180 º; structure 8*(H11 
detached from C10); Structure 9**(H12 detached from C10) 
 
NBO5 calculations (with assistance from Dr. Timeragazin) were used to determine the major 
contributing resonance structures for a model compound to represent the NAD(P)(H)cofactor. In 
order to analyze the X ≈ 0 º and X ≈ 180 º structures, the simplest model of NAD(P)(H) was used, 
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shown in Figures 2.4.1 and Figure 2.4.2 (Acrylamide) and Figure 2.4.3 and Figure 2.4.4 
(Methacrylamide).  
Figure 2.4.1 and Figure 2.4.3 summarize calculations for X ≈ 0 º and Figure 2.4.2 and Figure 
2.4.4 for X ≈ 180 º structures. The NAD(P)(H) structure from figure 2.2.27 represents the target 
structure for this study, in terms of trying to better understand factors that stabilize reactive 
intermediates and transitions states in oxidoreductase hydride transfer reactions.  
For Acrylamide, there is a 3.12 % contribution from one resonance structure of X ≈ 0 º, which 
has a positive charge on Carbon 1 (Figure 2.4.1).  Likewise, there is a 2.90% contribution from 
one resonance structure of X ≈ 180 º, which has a positive charge on Carbon 1 (figure 2.4.2). So, 
the X ≈ 0 º structure produces more positive charge contribution on this carbon, as required by 
figure 2.2.27.   
For Methacryamide, there is a 2.66 % contribution from one resonance structure of X ≈ 0 º, 
which has a positive charge on Carbon 7 (Figure 2.4.3) which is C1 from (Figure 2.4.1).  
Likewise, there is a 2.31% contribution from one resonance structure of X ≈ 180 º, which has a 
positive charge on Carbon 7 (Figure 2.4.4) which is on Carbon 1 (figure 2.4.2). So, the X ≈ 0 º 
structure produces more positive charge contribution on this carbon, as required by figure 2.2.27.   
 
2.5 Spectroscopic analysis of NAD(P)(H): calculation of NMR chemical shifts 
 
The X ≈ 180 ºand X ≈ 0 ºstructures of Nicotinamide Nucleoside and oxidized and reduced 
Nicotinamide were obtained from the rotational energy calculation. These structures were used 
for NMR chemical shift calculations (Figure 2.5.1) using Gaussian 9 with NMR=GIAO. Also, X 
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≈ 180 ºand X ≈ 0 ºstructures of Nicotinamide Nucleoside in air and in water solution were 
compared.  
Calculated NMR chemical shifts of Oxidized Nicotinamide Nucleoside and Nicotinamide were 
compared. Hydrogen H4, H5, H9 and Nitrogen N3 were more shielded and shifted upfield in 
Nicotinamide (Table 2.5.2) compared to Nicotinamide Nucleoside, due presence of the Ribose, 
which is acting as an electron withdrawing group, taking electron density away from Pyridine 
ring in Nicotinamide Nucleoside and deshielding it. In particular, H9 in Pyridine was 
significantly deshielded.  
H5 of Oxidized Nicotinamide Nucleoside and Nicotinamidewas less shielded than H4. However, 
H5 of reduced Nicotinamide Nucleoside showed the opposite trend. H5 of reduced Nicotinamide 
Nucleoside was more shielded than H4. H5 of reduced Nicotinamide stays same, H5 of that is 
less shielded than H4 of that.   
 
Figure 2.5.1 NMR chemical shift calculations for X ≈ 0 and 180 º structures of Oxidized 
Nicotinamide Nucleoside, Reference: TMS B3LYP/6-311+G(2d,p) GIAO 
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  H4 H5 N3 H9 *H9' 
X ≈ 0 ºOxidized Nicotinamide Nucleoside 4.4184 4.47658 94.4017 8.5492 
 X ≈ 180 ºOxidized Nicotinamide Nucleoside 4.77789 4.61491 94.4251 9.4132 
 X ≈ 0 ºOxNicotinamide Nucleoside in water 4.4184 4.47658 94.4017 8.5492 
 X ≈ 180 ºOxNicotinamide Nucleoside in 
water 4.77789 4.61491 94.4251 9.4132 
 X ≈ 0 ºOxidized Nicotinamide 4.5814 4.3463 94.656 8.9009 
 X ≈ 180 ºOxidized Nicotinamide 4.8669 4.7703 94.9359 7.8897 
 X ≈ 0 ºReduced Nicotinamide 2.7795 3.0324 85.9732 2.3808 2.9138 
X ≈ 180 ºReduced Nicotinamide 2.9816 3.2146 90.8374 2.6806 2.487 
Table 2.5.2 Calculated NMR chemical shifts in ppm units. *H9’, additional Hydrogen attached 
on C8 when NAD(P)+ is reduced. (See figure 1.5.1.) 
 
2.6 Results and Discussion 
Rotational energy calculations were performed for the carboxamide group in Nicotinamide 
Nucleoside, Nicotinamide, and the Propene-carboxamide, by rotating the carboxamide in 10 º 
increments from 0 º to 360 º. When the Dihedral angle of O2-C1-C6-C8 (Figure 2.2), X, is close 
to 0 º or 180 º, the structure of the derivatives of NAD(P)(H) was stabilized, due to resonance 
contributions from the pyridine
19,20
.  But, the dihedral angle of O2-C1-C6-C8 positions the 
carboxamide out of plane, with the double bonds in the ring and strain of the П-bonds being 
distorted and destabilized 
19,20
. The electron density of Nitrogen (N15) in Pyridine enhances 
Pyridine resonance structures with П-bonds on one side more than that on the other side. This 
effect makes the structure of X=0 º more stable thanthat of X = 180 º. The energy effect from this 
nitrogen was 7.7 KJ/mole in Nicotinamide.  
In the studies presented herein, there was another question that arose. When the dihedral angle X 
is close to 0 º or 180 º, there is an energy increase, a destabilization. This was caused by pyridine 
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ring distortions, involving steric clash between amide hydrogens and the pyridine ring
19
. The 
effect of these distortions were bigger than that of resonance stabilization in the X=0 º or X=180 
º structures. The destabilization energy occurring in the pyridine ring, and causing distortion, was 
measured (Figure 2.2.1). The distortion energy in the X=0 º structure is 2.9 KJ/mole, which was 
bigger than that in X=180 º structure of 0.4KJ/mole. Therefore, the distortion in the X=0 º 
structure was larger than that in X=180 º structure by 2.5 KJ/mole.  
This was confirmed with the pyridine structure analysis as had been proposed previously by 
Cook P. F. by dihedral angle calculations (Figure 2.2.28). The X ≈ 0 º structure was in a boat 
conformation, and was more distorted, with a dihedral angle range from 3.0º to -1.2 º; in contrast, 
the X ≈ 180 º structure was a distorted, but closer to planar, with a dihedral angle range from 0.4º 
to 0.0 º.   
The energy differences between X ≈ 0 º and X ≈ 180 º structures of Oxidized and Reduced 
Nicotinamide, and Oxidized Nicotinamide Nucleoside were 7.7 KJ/mole, 7.6 KJ/mole, and 5.0 
KJ/mole respectively. The energy difference of Oxidized Nicotinamide Nucleoside was smaller 
than that of Nicotinamide by 2.7 KJ/mole. Ribose acted as an electronic withdrawing group, and 
destabilized the resonance structure of Pyridine - this is supported by Charge and NMR analysis. 
The effect of destabilization energy from an electronic withdrawing group, Ribose, is 2.7 
KJ/mole.  
The energy difference of Oxidized and Reduced Nicotinamide was insignificant, at 0.1 KJ/mole. 
The structural difference of these forms needs to be studied more deeply.   
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2.7 Conclusion 
The energy effects of the carboxamide group rotation relative to the pyridine structure were 
dominated by four main factors: Resonance stabilization effect, Nitrogen electron withdrawing 
effect in the Pyridine ring, Distortion effect in the Pyridine ring due to H…H clashing, and 
Ribose ring effect.  
Resonance stabilization effect was maximized when X is equal to 0 º and 180 º with X = ≈ 180 º 
being more stable. 
Nitrogen effect in Pyridine ring affects resonance stabilization energy difference (Different 
resonance weight on each side of pyridine ring) between X ≈ 0 º and X ≈ 180 º conformations, 
and is responsible in part for creating the preference for X ≈ 180 º via its electron withdrawal 
from the adjacent carbon.  
Distortion effect in Pyridine ring destablizes resonance stabilization effect.   
Ribose ring weakens the Nitrogen electron withdrawing effect in the Pyridine ring, perhaps via 
electron donation due to the lone pair from oxygen. This could be proved by repeating 
calculations in the Anti orientation.   
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